Even though the greater part of U.S.-based cannabis organizations and lots of foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a couple of marijuana businesses are exchanged in the NASDAQ. Some investors prefer shares being noted on the NASDAQ with other exchanges because of their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. As an example, given that cannabis industry has exploded in current months and years, uplisting from an OTC market to an established U.S. change is actually an advertising achievement for all marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An increasing amount of marijuana businesses are now being noted on reputable U.S. exchanges as opposed to being exchanged in the OTC market showing the quick development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ had been the very first exchange that is electronic is definitely synonymous with technology and biotechnology. The cannabis businesses on the NASDAQ mirror this, plus the most of them run into the biotech area of this industry. Here you will find the NASDAQ-listed cannabis stocks, in alphabetical purchase, at the time of October 26, 2019, with a failure of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is really a biotech business active in the production of medical marijuana medications. Research and development around Arena’s APD371 could be the focus that is primary of firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is just a blank check business that is currently in a merger contract with Kalyx Development Inc. Kalyx is a prominent investment rely upon the regulated cannabis industry in the usa.

Key cbd oils Takeaways

• The cannabis industry, specially the section of cannabis and biotech, is attracting investor attention that is substantial.
• Cannabis has been found in brand new medications to treat discomfort and chronic that is many inflammatory, and fibrotic diseases.
• Organizations are developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (an inherited disorder), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing new chemical entities for the indications of discomfort and pruritus (itching). Although most of the company’s clinical-stage items target opioid receptors, Cara happens to be performing preclinical research on cannabinoids to treat neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and manufacturing are based around cannabis medications that seek to take care of chronic, inflammatory, fibrotic, as well as other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is a cannabis that are canadian. The team owns and seeks cannabis-related subsidiaries and licensed producers. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to fund its continued expansion but additionally with a partner that is well-established within the marketing of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage add-ons and vaporization equipment and items to retail clients in the U.S. and Canada. Also, it runs e-commerce sites for extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is creating a portfolio of cannabinoid medications. These medications consist of Sativex to treat spasticity pertaining to sclerosis that is multiple cancer discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than the usual dozen nations away from united states of america and contains received regulatory approval in various other nations. Epidiolex received Food And Drug Administration approval as a therapy plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of severe, very early beginning epilepsy without good existing treatment plans. Other indications show that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical business that is developing medications predicated on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based drugs for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now appropriate to be used on cannabis plants into the California cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern Beverages Corp. is really a maker of beverages based on yerba mate, green tea extract, kombucha, and comparable services and products. In current months, modern age has expanded its beverage offerings to add CBD infusions too, bringing it into the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, rendering it the most present cannabis businesses to record in the popular change. The organization is quickly expanding its manufacturing capability and may even have the ability to create up to 113,000 kilograms of product per 12 months because of the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs within the enforcement sector. The company’s business operations support drug testing through hair samples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another new entry on the NASDAQ exchange. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) when it announced the production of a fresh Palmetto make of recreational cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is really a specialty clinical-stage pharmaceutical business concentrated in the development of cannabinoid-based medications. Therapix’s present pipeline includes items targeted to treat Tourette problem and mild intellectual disability.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being the very first marijuana-related business to have a preliminary public providing (IPO) in the United States. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis items.

Village Farms Global (NASDAQ:VFF)

Village Farms Overseas is one of current cannabis stock to begin exchanging from the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The business possesses history that is decades-long greenhouse produce manufacturing and has only recently shifted a few of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted regarding the growth of synthetic treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline currently includes two drugs being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.